<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57" class="ref">
 <mixed-citation publication-type="journal" class="mixed-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Morimoto</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Toyota</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Satoh</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Murai</surname>
    <given-names class="given-names">M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Mita</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Suzuki</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Takamura</surname>
    <given-names class="given-names">Y.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ikeda</surname>
    <given-names class="given-names">H.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Ishida</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Sato</surname>
    <given-names class="given-names">N.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Tokino</surname>
    <given-names class="given-names">T.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Imai</surname>
    <given-names class="given-names">K.</given-names>
   </name>
  </person-group> (
  <year class="year">2004</year>). 
  <article-title class="article-title">Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-gamma in haematopoietic tumour cells</article-title>. 
  <source class="source">Br. J. Cancer</source>
  <volume class="volume">90</volume>, 
  <fpage class="fpage">844</fpage>â€“
  <lpage class="lpage">852</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1038/sj.bjc.6601602</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">14970863</pub-id>
 </mixed-citation>
</ref>
